U.S. House passes $8.3 billion bill to battle coronavirus; Senate vote
due Thursday
Send a link to a friend
[March 05, 2020]
By David Morgan and Richard Cowan
WASHINGTON (Reuters) - The U.S. House of
Representatives overwhelmingly approved on Wednesday an $8.3 billion
bill to combat the spread of the new coronavirus and develop vaccines
for the highly contagious disease, sending it to the Senate for final
passage.
Reflecting the urgency among lawmakers to address the growing
coronavirus crisis, the House voted 415-2 on the bill just hours after
negotiators unveiled its contents.
A Senate vote was scheduled for Thursday.
It includes money to expand testing for the virus, which has infected at
least 129 people in the United States. Two more deaths were reported on
Wednesday, taking the U.S. toll to 11.
With the White House backing the effort, congressional leaders worked to
win fast passage so that President Donald Trump could potentially sign
it into law this week.
"We must quickly enact this legislation. Lives are at stake," House
Appropriations Committee Chairwoman Nita Lowey, a Democrat, said in a
statement.
The measure would provide far more money than the $2.5 billion initially
sought by the Trump administration.
Shortly before the vote, the top four Democratic and Republican leaders
in Congress received a classified briefing about contingency plans for
Congress if there was a coronavirus outbreak in Washington.
An estimated 3 million people come through the Capitol Visitor Center
each year.
Following the meeting, the lawmakers brushed off reporters' questions on
whether plans were needed for Congress to meet somewhere else or whether
public access to the Capitol might eventually be curtailed.
Representative Matt Gaetz, after a separate closed briefing for
Republican lawmakers with Vice President Mike Pence about coronavirus
preparations nationwide, compared the House chamber to a "petri dish"
for incubating germs.
"We all fly in these dirty airports, we touch and selfie everyone we
meet and then we congregate together," the Florida congressman said.
Later, during the vote, Gaetz was spotted sitting in the House chamber
wearing a gas mask.
'NOT WHERE WE WANT TO BE'
Under the bill, over $3 billion would be devoted to research and
development of coronavirus vaccines, test kits and therapeutics. No
vaccines or treatments for the virus are currently in place, but
patients can receive supportive care.
[to top of second column]
|
President Donald Trump is flanked by Health and Human Services (HHS)
Secretary Alex Azar and National Institutes of Health Doctor
Kizzmekia Corbett, research fellow at the NIH Vaccine Research
Center, as he listens to Director of National Institute of Allergy
and Infectious Diseases Anthony Fauci following a briefing at the
Vaccine Research Center in Bethesda, Maryland, U.S., March 3, 2020.
REUTERS/Leah Millis
Gaetz said that while the United States was gearing up in the
production of virus test kits, "we're not where we want to be. The
vice president made that very clear that we've got to get more test
assets in place."
In a bid to also help control the spread of the virus outside the
United States, $1.25 billion would be available for international
efforts.
The fast-spreading virus that emerged late last year in central
China is now in some 80 countries. It has killed more than 3,000
worldwide and rattled financial markets.
State and local governments would receive $950 million to support
their work in combating the respiratory disease.
Senate Appropriations Committee Chairman Richard Shelby, a
Republican, called the bill "an aggressive and comprehensive
response" to the crisis.
Included is more than $300 million to help cover costs of any
vaccine for those who cannot afford it. The Department of Health and
Human Services would be authorized to ensure vaccines' affordability
in the commercial market.
Republicans cited a $7.8 billion cost for the bill, instead of $8.3
billion. That does not include $500 million authorized for a "telehealth"
program for senior citizens.
Other provisions in the bill:
** $2.2 billion in public health funding for prevention,
preparedness and response, including the $950 million to bolster
state and local government efforts.
** Nearly $1 billion to help procure drugs and medical supplies
** Small businesses affected by an outbreak could qualify for
low-interest federal loans.
(Reporting by Richard Cowan and David Morgan; Editing by Grant
McCool and Peter Cooney)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |